Menu
Back to User profile » Professor Xiaoyuan Xu
Papers published by Professor Xiaoyuan Xu:
Noninvasive Methods for Detecting Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B: A Single-Center Retrospective Study
Cheng R, Tan N, Luo H, Kang Q, Xu X
Infection and Drug Resistance 2023, 16:6323-6331
Published Date: 25 September 2023
Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis
Cheng R, Xu X
Journal of Hepatocellular Carcinoma 2022, 9:987-997
Published Date: 12 September 2022
Resistant-Associated Substitutions Do Not Affect HCV RNA and HCV Core Antigen Clearance During Direct-Acting Antiviral Agent Treatment in a Real-World Setting
Chen H, Liu J, Kang Q, Luo H, Tan N, Pan J, Yang Y, Yu M, Liu D, Xi H, Han Y, Cheng R, Yu Y, Xu X
Infection and Drug Resistance 2022, 15:3373-3380
Published Date: 28 June 2022
Predictive Nomograms for Clinical Outcomes in Hepatitis B-Related Cirrhosis Patients Receiving Antiviral Therapy
Cheng R, Xu J, Tan N, Luo H, Pan J, Xu X
Infection and Drug Resistance 2021, 14:2707-2719
Published Date: 15 July 2021
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
Wu X, Zhou J, Xie W, Ding H, Ou X, Chen G, Ma A, Xu X, Ma H, Xu Y, Liu X, Meng T, Wang L, Sun Y, Wang B, Kong Y, Ma H, You H, Jia J
Infection and Drug Resistance 2019, 12:745-757
Published Date: 1 April 2019